ストックスクリーナーアプリを入手
19.39
0.56%
-0.11
アフターアワーズ：
19.42
0.03
+0.15%
前日終値:
$19.50
開ける：
$20.8
24時間の取引高:
19.95M
Relative Volume:
0.61
時価総額：
$4.42B
収益：
$2.35B
当期純損益:
$128.37M
株価収益率:
37.14
EPS:
0.5221
ネットキャッシュフロー:
$57.42M
1週間 パフォーマンス:
-2.27%
1か月 パフォーマンス:
+23.19%
6か月 パフォーマンス:
-66.67%
1年 パフォーマンス:
-25.71%
1日の値動き範囲:
$19.04
$20.95
1週間の範囲:
$18.75
$20.95
52週間の値動き範囲:
$13.74
$70.43
Hims Hers Health Inc Stock (HIMS) Company Profile
Compare HIMS vs TAK, ZTS, HLN, TEVA, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
19.39 | 4.44B | 2.35B | 128.37M | 57.42M | 0.5221 |
TAK
Takeda Pharmaceutical Co Adr
|
18.66 | 57.78B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
119.75 | 49.30B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.97 | 44.03B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.52 | 34.15B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
581.69 | 24.79B | 3.18B | 1.33B | 1.04B | 27.90 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-10 | アップグレード | BofA Securities | Underperform → Neutral |
| 2026-03-10 | アップグレード | Citigroup | Sell → Neutral |
| 2026-03-09 | アップグレード | Needham | Hold → Buy |
| 2026-02-24 | ダウングレード | BTIG Research | Buy → Neutral |
| 2026-01-12 | 開始されました | Evercore ISI | In-line |
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-10-21 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2025-06-23 | ダウングレード | Needham | Buy → Hold |
| 2025-06-04 | 繰り返されました | Needham | Buy |
| 2025-04-29 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-02-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | ダウングレード | Citigroup | Neutral → Sell |
| 2025-01-07 | 開始されました | BTIG Research | Buy |
| 2024-12-17 | 開始されました | Morgan Stanley | Overweight |
| 2024-11-14 | ダウングレード | BofA Securities | Buy → Underperform |
| 2024-08-22 | 開始されました | Needham | Buy |
| 2024-08-09 | ダウングレード | Imperial Capital | Outperform → In-line |
| 2024-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-04-16 | ダウングレード | Jefferies | Buy → Hold |
| 2024-04-10 | 開始されました | Canaccord Genuity | Buy |
| 2024-02-28 | アップグレード | Imperial Capital | In-line → Outperform |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2023-12-07 | 開始されました | Imperial Capital | In-line |
| 2023-07-28 | 開始されました | TD Cowen | Outperform |
| 2023-04-11 | 開始されました | Robert W. Baird | Neutral |
| 2023-02-09 | アップグレード | Jefferies | Hold → Buy |
| 2022-11-08 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-11-08 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | 開始されました | Truist | Hold |
| 2022-07-15 | 開始されました | SVB Leerink | Underperform |
| 2022-04-14 | 開始されました | Guggenheim | Buy |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2022-03-10 | 開始されました | Deutsche Bank | Hold |
| 2021-12-02 | 開始されました | Jefferies | Hold |
| 2021-11-11 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | 開始されました | BofA Securities | Neutral |
| 2021-05-20 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | 開始されました | Truist | Hold |
| 2021-03-09 | 開始されました | Credit Suisse | Neutral |
| 2021-03-02 | アップグレード | Citigroup | Neutral → Buy |
| 2021-02-17 | 開始されました | Citigroup | Neutral |
| 2021-02-12 | 開始されました | Piper Sandler | Neutral |
| 2021-02-08 | 開始されました | Tigress Financial | Buy |
すべてを表示
Hims Hers Health Inc (HIMS) 最新ニュース
Hims & Hers Health stock rises as FDA-approved Wegovy and Ozempic come back to market - Traders Union
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm - globenewswire.com
Hims & Hers Health Is No Longer What The Market Thinks (NYSE:HIMS) - Seeking Alpha
BofA cuts Hims and Hers stock price target on EBITDA concerns - investing.com
HIMS Stock Jumps Premarket: CEO Targets 100K Monthly Wegovy Push After Novo Nordisk Truce - Stocktwits
Okupe, Hims & Hers health CFO, sells $79k in shares - Investing.com India
Hims & Hers Health, Inc. (HIMS) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Hims & Hers Faces Legal Scrutiny as Novo Nordisk Partnership Ends - timothysykes.com
Hims & Hers Faces Legal Scrutiny After Novo Nordisk Ends Partnership - timothysykes.com
Hackers access names, contact information of some Hims customers - Modern Healthcare
Hims & Hers Health (HIMS) Is Up 8.3% After Expanding Novo Nordisk GLP-1 Partnership And Launching New Weight-Loss MembershipHas The Bull Case Changed? - Yahoo Finance
3 Sectors to Buy While They’re Down and 1 to Walk Away From - Investing.com
Hims & Hers Health stock falls as insider files to sell shares - investing.com
Why Is HIMS Stock Slipping Premarket Today? - Stocktwits
Hims & Hers Health and Fortune Brands Innovation have been highlighted as Zacks Bull and Bear of the Day - Zacks Investment Research
3 Sectors to Buy While They're Down and 1 to Walk Away From - MarketBeat
Hims & Hers Health, Inc. (82W.F) Stock Price, News, Quote & History - Yahoo! Finance Canada
Hims & Hers Health, Inc. (HIMS) stock price, news, quote and history - Yahoo Finance UK
Hims & Hers (HIMS) Taps Into $200-Billion Weight Loss Market, Soars 6% - insidermonkey.com
Hims & Hers Health, Inc. (HIMS) Stock Price, News, Quote & History - Yahoo! Finance Canada
NewsHims & Hers Health announces breach affecting patients' personal data - teiss
Hims & Hers says limited data stolen in social engineering attack - Healthcare Dive
Hims & Hers shares rise as investors refocus on growth outlook despite recent data-breach disclosure - Quiver Quantitative
Hims & Hers Advances a Consumer-Centric Digital Health Platform - The Globe and Mail
Hims & Hers Health (NYSE:HIMS) Shares Gap UpHere's Why - MarketBeat
Hims & Hers Skyrockets Post Novo Nordisk Collaboration Milestone - StocksToTrade
Hims & Hers Health stock climbs as price remains inside $18.90–$20.90 range - Traders Union
Hims & Hers Faces Investor Scrutiny Ahead of Quarterly Earnings - AD HOC NEWS
Hims & Hers Moves Forward with a Patient-Focused Online Healthcare Platform - Bitget
Best Healthcare Stocks To Add to Your WatchlistApril 5th - MarketBeat
2026-04-05 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Hims & Hers Health, Inc. (HIMS) And Encourages Shareholders to Reach Out | NYSE:HIMS | Press Release - Stockhouse
Hims & Hers Health, Inc. (NYSE:HIMS) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Hims & Hers Health Inc at Morgan Stanley Technology, Media & Telecom Conference Transcript - GuruFocus
Hims Data Breach Tests Trust As Valuation Gap Attracts Investors - Yahoo Finance
Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Dir - PharmiWeb.com
Novo partnership fuels long-term optimism for Hims & Hers Health, Inc. (HIMS) - MSN
Data Breach Alert: Edelson Lechtzin LLP Investigates Hims & Hers, Inc. Data Breach - PR Newswire
Hims & Hers Health Faces Investor Lawsuit Over Alleged Misconduct - National Today
Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc.HIMS - Business Wire
Hims & Hers hack: Telehealth company reports customer support system breach - The American Bazaar
Here's Why Hims & Hers Health, Inc. (HIMS) Fell More Than Broader Market - MSN
Barclays raises PT on Hims & Hers Health (HIMS) stock - MSN
HIMS Stock Gains As FDA Reportedly Moves Toward Lifting Restrictions On Peptides - Stocktwits
Healthcare Stocks To Watch TodayApril 3rd - MarketBeat
Hims & Hers warns of data breach after Zendesk support ticket breach - BleepingComputer
Hims and Hers reveal cyberattack — customer support system hacked and personal info stolen, here's what we know - TechRadar
Here is what to know beyond why Hims & Hers Health, Inc. (HIMS) is a trending stock - MSN
Hims & Hers' Valuations Back To EarthRobust Monetization Trends Deserve Reiterated Buy - Seeking Alpha
Hims & Hers Health stock price forecast: sideways consolidation likely as HIMS falls 3.53% - Traders Union
Here is What to Know Beyond Why Hims & Hers Health, Inc. (HIMS) is a Trending Stock - Yahoo Finance
HIMS stock gains as FDA reportedly moves toward lifting restrictions on peptides - MSN
Hims Hers Health Inc (HIMS) 財務データ
収益
当期純利益
現金流量
EPS
2.24%
大文字化:
|
ボリューム (24 時間):